Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Gabon

Gabon

In Gabon, the revenue in the Other Vaccines market is estimated to reach US$1.97m in 2024.
It is anticipated that the revenue will experience a compound annual growth rate (CAGR 2024-2029) of 9.63%, resulting in a market volume of US$3.12m by 2029.
When compared globally, United States is expected to generate the highest revenue in this market, amounting to US$24,730.00m in 2024.
Gabon has seen an increasing demand for other vaccines due to the government's focus on expanding healthcare access.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Gabon has been showing interesting trends in recent years.

Customer preferences: Gabon is a country that has been experiencing a steady increase in its population, with a growing demand for healthcare services. The population's awareness of the importance of vaccination has been increasing, and there is a growing interest in vaccination programs. The government has been actively working to improve the country's healthcare system, which has led to an increase in the availability of vaccines.

Trends in the market: The Other Vaccines market in Gabon has been growing steadily in recent years. There has been an increase in the demand for vaccines, driven by the growing awareness of the importance of vaccination and the government's efforts to improve the healthcare system. The market has been expanding, with new vaccines being introduced, and there has been a growing interest in vaccination programs.

Local special circumstances: Gabon is a country with a relatively high GDP per capita compared to other African countries. This has allowed the government to invest in the healthcare system, which has had a positive impact on the availability of vaccines. However, the country still faces challenges in terms of infrastructure and distribution, which can make it difficult to reach all parts of the population.

Underlying macroeconomic factors: The Gabonese economy is heavily dependent on the oil industry, which has been facing challenges in recent years. This has led to a slowdown in economic growth, which can have an impact on the healthcare system. However, the government has been working to diversify the economy and reduce its reliance on the oil industry, which could have a positive impact on the healthcare system in the long term.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.